Question 1

Purpose Test

Accepted Answer

Primary use: pre-transfusion compatibility testing (Crossmatch) to detect any irregular antibodies in the recipient’s blood that may attack donor red blood cells, preventing serious hemolytic reactions. Testing pregnant women (especially Rh-negative) to detect formation of antibodies against fetal blood antigens (e.g., anti-D), which may cause hemolytic disease of the newborn (HDN) in the current or future pregnancies. Testing individuals who have previously received blood transfusions, as prior exposure may stimulate production of irregular antibodies. Investigating potential causes of hemolytic anemia, alongside the direct Coombs test.

Question 2

Recommended groups

Accepted Answer

All patients requiring blood or blood component transfusions (e.g., surgery, bleeding, severe anemia, etc.). All pregnant women as a routine test in the first trimester. Patients with a history of adverse reactions after blood transfusion. Individuals with a history of recurrent miscarriages or unexplained fetal deaths. Individuals with a history of recurrent miscarriages or unexplained fetal deaths.

Question 3

Symptoms indicative

Accepted Answer

There are no direct symptoms, as it is a routine preventive test. It is mandatory before any surgical procedure that may require a blood transfusion. It is requested as part of routine prenatal care. It is requested as part of routine prenatal care.

Question 4

Frequently Asked Questions (FAQs)

Accepted Answer

Indirect (IAT): Detects free antibodies in plasma before they can attach to red blood cells. It answers the question: "Does your blood have weapons (antibodies) ready to attack foreign blood?" Used for prevention. Direct (DAT): Detects antibodies already attached to red blood cells after a reaction has occurred. It answers the question: "Is your immune system attacking your red blood cells now?" Used for diagnosis. The antibody must be accurately identified to know which antigen it targets. Blood provided to the patient in the future must be free of that antigen if transfusion is needed. During pregnancy, the fetus must be closely monitored if the father carries that antigen.

Question 5

Normal Levels

Accepted Answer

The normal result is negative, meaning no detectable irregular antibodies are present in the patient’s serum against the standard test cell panel. A positive result is reported with identification of the detected antibody (e.g., anti-D, anti-Kell, anti-E). The antibody titer may also be reported, especially in pregnancy, as a higher titer indicates an increased risk of fetal involvement.

Indirect Coombs Test